Supriya Lifescience
724.50
+15.45(+2.18%)
Market Cap₹5,706.60 Cr
PE Ratio31.01
IndustryHealthcare
Company Performance:
1D+2.18%
1M+1.11%
6M-4.23%
1Y+82.04%
5Y+85.37%
View Company Insightsright
Latest news about Supriya Lifescience
Supriya Lifescience Faces ₹603.8 Crore Tax Demand 7 hours ago Yesterday
Supriya Lifescience, a pharmaceutical company, has received a tax demand notice of ₹603.80 crore from the Tax Department. The company has not provided specific details about the nature of the tax assessment or the period it covers. This substantial demand could potentially impact the company's finances and operations. Investors are awaiting further information and the company's response to this development.
Supriya Lifescience Unveils Ambitious Growth Strategy, Targets ₹1,000 Crore Revenue by FY27 May 29, 2025
Supriya Lifescience Reports Strong Q4 Results, Announces Dividend May 27, 2025